Global Pruritus Drugs Market 2019-2023 | Nanoparticle-Enabled Transdermal Drug Delivery Systems to Boost Growth | Technavio

LONDON–(BUSINESS WIRE)–#Biotechnology–The global pruritus drugs market is expected to post a CAGR of over 5% during the period 2019-2023, according to the latest market research report by Technavio.

A key factor driving the growth of the market is the growing preference for immunotherapy. The global oncology therapeutics market has been exposed to significant advances in terms of drug development, with various novel targeted therapies. However, these drugs are known to make the skin dry leading to rashes and hair loss due to itching in the scalp. Pruritus is a common side effect associated with immunotherapy in patients with cancer. Although it is not a fatal condition, pruritus is highly morbid in nature and is known to significantly affect the quality of life of patients. Thus, the rising use of immunotherapy is expected to increase the cases of pruritus, which will drive the growth of the market during the forecast period.

As per Technavio, the nanoparticle-enabled transdermal drug delivery systems will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global pruritus drugs market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.

Global Pruritus Drugs Market: Nanoparticle-Enabled Transdermal Drug Delivery Systems

Transdermal drug delivery systems have been used for decades for the delivery of pruritus drugs. However, this method of drug delivery is not applicable for the delivery of small and lipophilic drugs, which can permeate through the skin barrier. In recent years, novel approaches have been developed, which utilize nanoparticles for the delivery of small drugs. Nanoparticles or nanocarriers are synthesized using polymers, lipids, or metals on the nanometer scale. As the name suggests, these particles are of minute sizes and can easily permeate through the skin barrier, opening the potential to enter various cellular compartments, including the nucleus. The availability’ of biodegradable polymeric nanoparticles has impelled R&D in this area as these carriers have helped increase the half-life of the drug and offer strong drug entrapment efficiency. Thus, such advances in the delivery of pruritus drugs, are anticipated to positively impact the growth of the market during the forecast period.

“Apart from the nanoparticle-enabled transdermal drug delivery systems, the emergence of novel treatment options, and increasing research funding are two other major aspects that are expected to boost market growth during the forecast period,” says a senior analyst at Technavio.

Global Pruritus Drugs Market: Segmentation Analysis

This market research report segments the global pruritus drugs market by application (hematologic pruritus, oncological pruritus, renal pruritus, endocrine pruritus, and cholestatic pruritus) and geographical regions (North America, Europe, Asia, and ROW).

The North American region led the market in 2018, followed by Europe, Asia, and ROW respectively. However, during the forecast period, the Asian region is expected to register the highest incremental growth due to the presence of a large patient population in the region.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

• Market ecosystem
• Market characteristics
• Market segmentation analysis

Market Sizing

• Market definition
• Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

• Regional comparison
• Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at [email protected].

Contacts

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com